| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.846 | 0.01 | 0.889 | Antiinflammatory | 0.822 0.013 DBMET01188 0.883 0.006 DBMET01190 0.847 0.01 DBMET01837 0.75 0.022 DBMET01189 0.889 0.005 DBMET01191 | DBMET01191 | |
| 0.824 | 0.014 | 0.824 | Apoptosis agonist | 0.765 0.021 DBMET01188 0.434 0.098 DBMET01190 0.77 0.02 DBMET01837 0.634 0.042 DBMET01189 0.698 0.031 DBMET01191 | ||
| 0.656 | 0.002 | 0.756 | Vanilloid agonist | 0.756 0.002 DBMET01188 0.095 0.039 DBMET01190 0.429 0.004 DBMET01837 0.412 0.004 DBMET01189 0.085 0.058 DBMET01191 | DBMET01188 | |
| 0.656 | 0.005 | 0.661 | Psychostimulant | 0.661 0.005 DBMET01188 0.359 0.03 DBMET01190 0.508 0.01 DBMET01837 0.274 0.05 DBMET01189 0.299 0.043 DBMET01191 | DBMET01188 | |
| 0.654 | 0.007 | 0.755 | Immunosuppressant | 0.553 0.02 DBMET01188 0.532 0.025 DBMET01190 0.755 0.004 DBMET01837 0.621 0.011 DBMET01189 0.599 0.013 DBMET01191 | DBMET01837 | |
| 0.609 | 0.003 | 0.609 | TRPA1 agonist | 0.241 0.006 DBMET01188 0.137 0.041 DBMET01190 0.196 0.011 DBMET01837 0.19 0.013 DBMET01189 | ||
| 0.562 | 0.012 | 0.601 | Nitric oxide antagonist | 0.574 0.011 DBMET01188 0.525 0.014 DBMET01190 0.588 0.01 DBMET01837 0.361 0.03 DBMET01189 0.601 0.01 DBMET01191 | DBMET01191 | |
| 0.541 | 0.01 | 0.774 | Angiogenesis stimulant | 0.446 0.016 DBMET01188 0.314 0.044 DBMET01190 0.374 0.027 DBMET01837 0.381 0.025 DBMET01189 0.774 0.004 DBMET01191 | DBMET01191 | |
| 0.507 | 0.004 | 0.507 | 5 Hydroxytryptamine uptake stimulant | 0.496 0.004 DBMET01188 0.223 0.113 DBMET01190 0.469 0.005 DBMET01837 0.496 0.004 DBMET01189 | ||
| 0.511 | 0.043 | 0.868 | Transcription factor NF kappa B inhibitor | 0.57 0.035 DBMET01188 0.49 0.046 DBMET01190 0.622 0.029 DBMET01837 0.401 0.063 DBMET01189 0.868 0.009 DBMET01191 | DBMET01191 | |
| 0.432 | 0.009 | 0.658 | Platelet adhesion inhibitor | 0.38 0.014 DBMET01188 0.512 0.005 DBMET01190 0.329 0.025 DBMET01837 0.327 0.026 DBMET01189 0.658 0.004 DBMET01191 | DBMET01191 | |
| 0.402 | 0.005 | 0.678 | Expectorant | 0.547 0.003 DBMET01188 0.398 0.005 DBMET01190 0.611 0.003 DBMET01837 0.325 0.007 DBMET01189 0.678 0.002 DBMET01191 | DBMET01191 | |
| 0.43 | 0.034 | 0.566 | Spasmolytic | 0.489 0.025 DBMET01188 0.566 0.016 DBMET01190 0.32 0.063 DBMET01837 0.431 0.034 DBMET01189 0.56 0.017 DBMET01191 | DBMET01190 | |
| 0.385 | 0.025 | 0.385 | Antimitotic | 0.281 0.049 DBMET01837 | ||
| 0.377 | 0.027 | 0.377 | Vasodilator | 0.335 0.037 DBMET01188 0.342 0.035 DBMET01837 0.307 0.046 DBMET01191 | ||
| 0.376 | 0.031 | 0.48 | Tumour necrosis factor alpha release inhibitor | 0.358 0.036 DBMET01188 0.228 0.086 DBMET01190 0.27 0.066 DBMET01837 0.256 0.072 DBMET01189 0.48 0.016 DBMET01191 | DBMET01191 | |
| 0.377 | 0.039 | 0.551 | Antioxidant | 0.385 0.038 DBMET01188 0.177 0.135 DBMET01190 0.363 0.043 DBMET01837 0.238 0.09 DBMET01189 0.551 0.015 DBMET01191 | DBMET01191 | |
| 0.409 | 0.073 | 0.65 | Antibacterial | 0.43 0.064 DBMET01188 0.296 0.139 DBMET01190 0.532 0.032 DBMET01837 0.359 0.097 DBMET01189 0.65 0.013 DBMET01191 | DBMET01191 | |
| 0.417 | 0.101 | 0.506 | Caspase 9 stimulant | 0.506 0.058 DBMET01188 0.321 0.172 DBMET01190 0.453 0.082 DBMET01837 0.347 0.148 DBMET01189 0.379 0.124 DBMET01191 | DBMET01188 | |
| 0.307 | 0.003 | 0.307 | Ca(v)3.1 blocker | 0.245 0.004 DBMET01188 0.236 0.004 DBMET01837 0.095 0.028 DBMET01189 | ||
| 0.332 | 0.034 | 0.406 | DNA synthesis inhibitor | 0.376 0.025 DBMET01188 0.276 0.053 DBMET01190 0.383 0.024 DBMET01837 0.351 0.03 DBMET01189 0.406 0.021 DBMET01191 | DBMET01191 | |
| 0.299 | 0.004 | 0.299 | GABA C receptor antagonist | 0.268 0.005 DBMET01188 0.169 0.021 DBMET01190 0.252 0.006 DBMET01837 0.214 0.01 DBMET01189 | ||
| 0.309 | 0.021 | 0.469 | Melanin inhibitor | 0.269 0.026 DBMET01188 0.195 0.043 DBMET01190 0.469 0.008 DBMET01837 0.319 0.02 DBMET01189 0.282 0.024 DBMET01191 | DBMET01837 | |
| 0.357 | 0.082 | 0.357 | GABA C receptor rho-3 antagonist | 0.223 0.18 DBMET01188 0.241 0.162 DBMET01837 0.223 0.18 DBMET01189 | ||
| 0.295 | 0.021 | 0.472 | Interferon gamma antagonist | 0.262 0.026 DBMET01188 0.258 0.027 DBMET01190 0.334 0.016 DBMET01837 0.262 0.026 DBMET01189 0.472 0.007 DBMET01191 | DBMET01191 | |
| 0.264 | 0.003 | 0.264 | TRPM8 blocker | 0.143 0.005 DBMET01188 0.052 0.015 DBMET01190 0.067 0.01 DBMET01837 0.046 0.018 DBMET01189 | ||
| 0.297 | 0.039 | 0.297 | Sigma receptor agonist | 0.122 0.111 DBMET01190 | ||
| 0.252 | 0.004 | 0.252 | CYP2A6 inhibitor | 0.103 0.035 DBMET01188 0.129 0.023 DBMET01837 | ||
| 0.253 | 0.005 | 0.297 | Vanilloid 1 agonist | 0.297 0.004 DBMET01188 0.155 0.034 DBMET01190 0.194 0.014 DBMET01837 0.234 0.006 DBMET01189 0.159 0.03 DBMET01191 | DBMET01188 | |
| 0.25 | 0.009 | 0.261 | Microtubule formation inhibitor | 0.221 0.015 DBMET01188 0.217 0.016 DBMET01190 0.261 0.006 DBMET01837 0.206 0.018 DBMET01189 0.257 0.007 DBMET01191 | DBMET01837 | |
| 0.275 | 0.038 | 0.358 | RNA-directed DNA polymerase inhibitor | 0.261 0.043 DBMET01188 0.358 0.023 DBMET01190 0.239 0.057 DBMET01837 0.325 0.027 DBMET01189 0.29 0.034 DBMET01191 | DBMET01190 | |
| 0.31 | 0.082 | 0.311 | Calcium channel activator | 0.282 0.111 DBMET01188 0.24 0.159 DBMET01190 0.311 0.081 DBMET01837 0.282 0.111 DBMET01189 | DBMET01837 | |
| 0.237 | 0.011 | 0.361 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.361 0.004 DBMET01188 0.186 0.018 DBMET01190 0.185 0.018 DBMET01837 0.235 0.011 DBMET01189 0.213 0.014 DBMET01191 | DBMET01188 | |
| 0.282 | 0.058 | 0.485 | Interleukin agonist | 0.318 0.04 DBMET01188 0.277 0.06 DBMET01190 0.305 0.045 DBMET01837 0.272 0.064 DBMET01189 0.485 0.01 DBMET01191 | DBMET01191 | |
| 0.239 | 0.017 | 0.337 | ATPase inhibitor | 0.152 0.098 DBMET01188 0.264 0.011 DBMET01190 0.337 0.004 DBMET01837 0.152 0.098 DBMET01189 0.337 0.004 DBMET01191 | DBMET01191 | |
| 0.303 | 0.084 | 0.437 | Apoptosis antagonist | 0.348 0.057 DBMET01188 0.302 0.084 DBMET01837 0.229 0.148 DBMET01189 0.437 0.03 DBMET01191 | DBMET01191 | |
| 0.291 | 0.073 | 0.308 | 5 Hydroxytryptamine release stimulant | 0.308 0.067 DBMET01188 0.27 0.08 DBMET01837 0.308 0.067 DBMET01189 | DBMET01189 | |
| 0.239 | 0.026 | 0.251 | Succinate dehydrogenase inhibitor | 0.251 0.022 DBMET01188 0.188 0.06 DBMET01190 0.223 0.033 DBMET01837 0.251 0.022 DBMET01189 | DBMET01189 | |
| 0.291 | 0.083 | 0.411 | Caspase 3 stimulant | 0.411 0.041 DBMET01188 0.348 0.06 DBMET01837 0.275 0.093 DBMET01189 0.245 0.117 DBMET01191 | DBMET01188 | |
| 0.21 | 0.005 | 0.21 | 5-Alpha-reductase inhibitor | 0.208 0.005 DBMET01188 0.09 0.011 DBMET01190 0.126 0.008 DBMET01837 0.114 0.009 DBMET01189 | ||
| 0.217 | 0.018 | 0.297 | Antineoplastic antibiotic | 0.179 0.025 DBMET01188 0.132 0.035 DBMET01190 0.297 0.01 DBMET01837 0.143 0.032 DBMET01189 0.257 0.013 DBMET01191 | DBMET01837 | |
| 0.196 | 0.014 | 0.375 | Mucolytic | 0.316 0.004 DBMET01188 0.284 0.005 DBMET01190 0.375 0.003 DBMET01837 0.273 0.005 DBMET01189 0.275 0.005 DBMET01191 | DBMET01837 | |
| 0.217 | 0.036 | 0.41 | Protein kinase stimulant | 0.41 0.008 DBMET01188 0.19 0.045 DBMET01190 0.295 0.017 DBMET01837 0.263 0.023 DBMET01189 0.24 0.029 DBMET01191 | DBMET01188 | |
| 0.2 | 0.022 | 0.2 | Ferrochelatase inhibitor | 0.117 0.055 DBMET01188 0.089 0.083 DBMET01190 0.139 0.042 DBMET01837 0.117 0.055 DBMET01189 | ||
| 0.199 | 0.022 | 0.234 | Farnesoid X receptor antagonist | 0.134 0.074 DBMET01188 0.234 0.014 DBMET01190 0.147 0.056 DBMET01837 0.138 0.068 DBMET01189 0.139 0.067 DBMET01191 | DBMET01190 | |
| 0.309 | 0.135 | 0.316 | Analgesic | 0.316 0.129 DBMET01189 | DBMET01189 | |
| 0.265 | 0.09 | 0.581 | Immunostimulant | 0.372 0.058 DBMET01188 0.349 0.065 DBMET01190 0.316 0.074 DBMET01837 0.335 0.069 DBMET01189 0.581 0.019 DBMET01191 | DBMET01191 | |
| 0.221 | 0.054 | 0.476 | Hepatoprotectant | 0.264 0.04 DBMET01188 0.194 0.068 DBMET01190 0.225 0.052 DBMET01837 0.239 0.046 DBMET01189 0.476 0.008 DBMET01191 | DBMET01191 | |
| 0.199 | 0.034 | 0.221 | Arachidonic acid antagonist | 0.192 0.041 DBMET01188 0.208 0.026 DBMET01190 0.221 0.017 DBMET01837 0.192 0.041 DBMET01189 0.136 0.105 DBMET01191 | DBMET01837 | |
| 0.22 | 0.057 | 0.543 | Non-steroidal antiinflammatory agent | 0.189 0.08 DBMET01188 0.306 0.027 DBMET01190 0.268 0.036 DBMET01837 0.202 0.069 DBMET01189 0.543 0.005 DBMET01191 | DBMET01191 | |
| 0.165 | 0.005 | 0.165 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 DBMET01188 0.159 0.006 DBMET01190 0.165 0.005 DBMET01837 0.105 0.033 DBMET01189 0.15 0.007 DBMET01191 | ||
| 0.234 | 0.076 | 0.463 | Free radical scavenger | 0.28 0.057 DBMET01188 0.265 0.063 DBMET01837 0.463 0.02 DBMET01191 | DBMET01191 | |
| 0.193 | 0.039 | 0.235 | Insulin secretagoues | 0.119 0.113 DBMET01188 0.123 0.106 DBMET01189 0.235 0.023 DBMET01191 | DBMET01191 | |
| 0.163 | 0.012 | 0.17 | Anabolic | 0.154 0.016 DBMET01188 0.159 0.014 DBMET01190 0.17 0.009 DBMET01837 0.144 0.021 DBMET01189 0.118 0.041 DBMET01191 | DBMET01837 | |
| 0.259 | 0.109 | 0.51 | Interleukin 2 agonist | 0.351 0.045 DBMET01188 0.265 0.103 DBMET01190 0.324 0.058 DBMET01837 0.282 0.088 DBMET01189 0.51 0.007 DBMET01191 | DBMET01191 | |
| 0.163 | 0.013 | 0.163 | Inducible nitric-oxide synthase inhibitor | 0.08 0.062 DBMET01837 | ||
| 0.194 | 0.045 | 0.22 | Acetylcholine M1 receptor antagonist | 0.22 0.034 DBMET01188 0.174 0.056 DBMET01837 0.136 0.088 DBMET01189 | DBMET01188 | |
| 0.263 | 0.116 | 0.731 | Cholesterol antagonist | 0.395 0.05 DBMET01188 0.48 0.036 DBMET01190 0.359 0.061 DBMET01837 0.389 0.052 DBMET01189 0.731 0.006 DBMET01191 | DBMET01191 | |
| 0.156 | 0.015 | 0.37 | Transcription factor NF kappa B stimulant | 0.37 0.003 DBMET01188 0.078 0.075 DBMET01190 0.141 0.018 DBMET01837 0.125 0.023 DBMET01189 0.153 0.015 DBMET01191 | DBMET01188 | |
| 0.142 | 0.004 | 0.145 | Vanilloid 4 agonist | 0.145 0.004 DBMET01188 0.082 0.038 DBMET01190 0.111 0.01 DBMET01837 0.107 0.012 DBMET01189 | DBMET01188 | |
| 0.164 | 0.029 | 0.171 | GABA C receptor agonist | 0.171 0.027 DBMET01188 0.149 0.034 DBMET01190 0.112 0.055 DBMET01837 0.171 0.027 DBMET01189 | DBMET01189 | |
| 0.17 | 0.035 | 0.186 | Adenylate cyclase stimulant | 0.186 0.021 DBMET01188 0.159 0.048 DBMET01190 0.183 0.023 DBMET01837 0.172 0.033 DBMET01189 | DBMET01188 | |
| 0.233 | 0.098 | 0.233 | Transcription factor STAT3 inhibitor | 0.188 0.151 DBMET01188 0.21 0.122 DBMET01190 0.189 0.149 DBMET01837 | ||
| 0.232 | 0.1 | 0.232 | Transcription factor STAT inhibitor | 0.204 0.133 DBMET01190 0.177 0.173 DBMET01837 | ||
| 0.155 | 0.023 | 0.273 | DNA directed RNA polymerase inhibitor | 0.102 0.054 DBMET01188 0.273 0.008 DBMET01190 0.112 0.044 DBMET01837 0.144 0.026 DBMET01191 | DBMET01190 | |
| 0.141 | 0.009 | 0.185 | Glycine receptor antagonist | 0.124 0.016 DBMET01188 0.092 0.041 DBMET01190 0.185 0.004 DBMET01837 0.104 0.029 DBMET01189 0.134 0.012 DBMET01191 | DBMET01837 | |
| 0.169 | 0.038 | 0.244 | Alkylator | 0.244 0.017 DBMET01188 0.099 0.089 DBMET01190 0.154 0.044 DBMET01837 0.109 0.078 DBMET01189 0.242 0.018 DBMET01191 | DBMET01188 | |
| 0.139 | 0.009 | 0.139 | Cannabinoid CB2 receptor antagonist | 0.104 0.014 DBMET01188 0.06 0.029 DBMET01190 0.093 0.017 DBMET01189 | ||
| 0.225 | 0.096 | 0.24 | Tyrosine 3 hydroxylase inhibitor | 0.214 0.112 DBMET01188 0.24 0.079 DBMET01190 0.198 0.139 DBMET01837 0.214 0.112 DBMET01189 | DBMET01190 | |
| 0.156 | 0.031 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.147 0.049 DBMET01188 0.171 0.012 DBMET01190 0.17 0.013 DBMET01837 0.147 0.049 DBMET01189 0.176 0.009 DBMET01191 | DBMET01191 | |
| 0.131 | 0.011 | 0.14 | Na+ K+ transporting ATPase inhibitor | 0.14 0.008 DBMET01188 0.117 0.018 DBMET01190 0.137 0.009 DBMET01837 0.128 0.012 DBMET01189 0.135 0.01 DBMET01191 | DBMET01188 | |
| 0.129 | 0.013 | 0.129 | GABA aminotransferase inhibitor | 0.123 0.015 DBMET01188 0.106 0.023 DBMET01190 0.099 0.027 DBMET01837 0.123 0.015 DBMET01189 0.118 0.017 DBMET01191 | ||
| 0.162 | 0.049 | 0.162 | M17 leucyl aminopeptidase inhibitor | 0.114 0.083 DBMET01188 0.133 0.067 DBMET01190 0.114 0.083 DBMET01189 | ||
| 0.136 | 0.025 | 0.136 | Acetylcholine nicotinic antagonist | 0.097 0.041 DBMET01188 0.076 0.059 DBMET01190 0.081 0.053 DBMET01837 0.082 0.053 DBMET01189 | ||
| 0.111 | 0.004 | 0.111 | Retinoid X receptor agonist | 0.101 0.005 DBMET01188 0.069 0.011 DBMET01190 0.068 0.011 DBMET01837 0.096 0.005 DBMET01189 | ||
| 0.175 | 0.069 | 0.175 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.217 | 0.112 | 0.217 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.126 | 0.022 | 0.149 | Ornithine decarboxylase inhibitor | 0.126 0.022 DBMET01188 0.112 0.032 DBMET01190 0.149 0.011 DBMET01837 0.128 0.02 DBMET01189 | DBMET01837 | |
| 0.131 | 0.028 | 0.133 | Androgen antagonist | 0.082 0.063 DBMET01188 0.133 0.028 DBMET01190 0.123 0.032 DBMET01837 0.078 0.068 DBMET01189 | DBMET01190 | |
| 0.109 | 0.006 | 0.121 | Kainate receptor antagonist | 0.121 0.005 DBMET01188 0.072 0.012 DBMET01837 0.063 0.015 DBMET01189 | DBMET01188 | |
| 0.105 | 0.003 | 0.105 | Kainate receptor agonist | 0.103 0.003 DBMET01188 0.049 0.015 DBMET01190 0.09 0.003 DBMET01837 0.085 0.003 DBMET01189 | ||
| 0.119 | 0.019 | 0.122 | CDC25A inhibitor | 0.122 0.019 DBMET01188 0.091 0.033 DBMET01837 0.122 0.019 DBMET01189 | DBMET01189 | |
| 0.101 | 0.002 | 0.101 | Tubulin agonist | 0.07 0.004 DBMET01188 0.06 0.005 DBMET01190 0.071 0.004 DBMET01837 0.07 0.004 DBMET01189 0.048 0.009 DBMET01191 | ||
| 0.152 | 0.054 | 0.341 | Alpha-N-acetylglucosaminidase inhibitor | 0.285 0.018 DBMET01188 0.244 0.024 DBMET01190 0.264 0.021 DBMET01837 0.285 0.018 DBMET01189 0.341 0.012 DBMET01191 | DBMET01191 | |
| 0.098 | 0.001 | 0.098 | Vanilloid 2 agonist | 0.074 0.002 DBMET01188 0.038 0.004 DBMET01190 0.067 0.002 DBMET01837 0.063 0.002 DBMET01189 0.052 0.003 DBMET01191 | ||
| 0.111 | 0.019 | 0.12 | HIV-1 integrase (Strand Transfer) inhibitor | 0.109 0.019 DBMET01188 0.12 0.016 DBMET01837 | DBMET01837 | |
| 0.095 | 0.002 | 0.095 | Adenosine uptake inhibitor | 0.049 0.005 DBMET01188 0.033 0.032 DBMET01190 0.039 0.014 DBMET01837 0.041 0.01 DBMET01189 | ||
| 0.301 | 0.211 | 0.301 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.108 | 0.019 | 0.172 | T cell inhibitor | 0.172 0.009 DBMET01837 0.082 0.058 DBMET01189 | DBMET01837 | |
| 0.104 | 0.019 | 0.161 | Glycine receptor agonist | 0.085 0.032 DBMET01188 0.12 0.012 DBMET01190 0.161 0.005 DBMET01837 0.085 0.032 DBMET01189 0.11 0.016 DBMET01191 | DBMET01837 | |
| 0.105 | 0.027 | 0.105 | Nicotinic alpha4beta2 receptor antagonist | 0.077 0.053 DBMET01189 | ||
| 0.122 | 0.045 | 0.122 | Electron transport complex I inhibitor | 0.099 0.085 DBMET01188 0.116 0.053 DBMET01837 0.099 0.085 DBMET01189 | ||
| 0.212 | 0.138 | 0.217 | Hypoxia-inducible factor 1 alpha inhibitor | 0.217 0.133 DBMET01837 | DBMET01837 | |
| 0.116 | 0.043 | 0.116 | GABA C receptor rho-1 antagonist | 0.102 0.06 DBMET01188 0.088 0.082 DBMET01837 0.102 0.06 DBMET01189 | ||
| 0.077 | 0.005 | 0.077 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.049 0.012 DBMET01188 0.052 0.01 DBMET01190 0.045 0.015 DBMET01837 0.044 0.016 DBMET01189 | ||
| 0.143 | 0.072 | 0.274 | Cell wall synthesis inhibitor | 0.196 0.031 DBMET01188 0.165 0.052 DBMET01190 0.144 0.072 DBMET01837 0.134 0.082 DBMET01189 0.274 0.012 DBMET01191 | DBMET01191 | |
| 0.128 | 0.057 | 0.147 | Protein-tyrosine phosphatase 1B inhibitor | 0.147 0.046 DBMET01188 0.14 0.05 DBMET01837 0.093 0.085 DBMET01189 0.103 0.075 DBMET01191 | DBMET01188 | |
| 0.074 | 0.005 | 0.074 | Microtubule stabilization | 0.06 0.015 DBMET01188 0.06 0.014 DBMET01190 0.067 0.008 DBMET01837 0.058 0.017 DBMET01189 0.065 0.009 DBMET01191 | ||
| 0.127 | 0.059 | 0.255 | Cholesterol synthesis inhibitor | 0.118 0.067 DBMET01188 0.255 0.017 DBMET01190 0.23 0.021 DBMET01837 0.143 0.049 DBMET01189 0.181 0.032 DBMET01191 | DBMET01190 | |
| 0.097 | 0.03 | 0.097 | Cannabinoid receptor antagonist | |||
| 0.071 | 0.004 | 0.081 | Glutamate (mGluR1) agonist | 0.081 0.004 DBMET01188 0.028 0.012 DBMET01837 0.05 0.005 DBMET01189 | DBMET01188 | |
| 0.126 | 0.061 | 0.171 | Beta amyloid protein antagonist | 0.101 0.088 DBMET01190 0.171 0.028 DBMET01191 | DBMET01191 | |
| 0.205 | 0.141 | 0.258 | Gastrin inhibitor | 0.258 0.07 DBMET01190 0.192 0.162 DBMET01191 | DBMET01190 | |
| 0.087 | 0.022 | 0.087 | Cannabinoid CB1 receptor antagonist | 0.057 0.049 DBMET01188 | ||
| 0.11 | 0.046 | 0.11 | Nitric-oxide synthase inhibitor | |||
| 0.212 | 0.149 | 0.212 | Prostaglandin dehydrogenase inhibitor | |||
| 0.084 | 0.023 | 0.084 | TRPA1 antagonist | |||
| 0.118 | 0.059 | 0.148 | Photosensitizer | 0.123 0.053 DBMET01188 0.148 0.032 DBMET01837 0.106 0.078 DBMET01189 0.143 0.036 DBMET01191 | DBMET01837 | |
| 0.081 | 0.023 | 0.088 | Glutamate (mGluR6) antagonist | 0.079 0.025 DBMET01188 0.088 0.017 DBMET01190 0.085 0.019 DBMET01837 0.079 0.025 DBMET01189 | DBMET01190 | |
| 0.126 | 0.068 | 0.143 | Cholinergic antagonist | 0.143 0.056 DBMET01188 0.122 0.072 DBMET01190 0.105 0.089 DBMET01189 | DBMET01188 | |
| 0.16 | 0.103 | 0.336 | Anesthetic general | 0.172 0.093 DBMET01188 0.249 0.051 DBMET01190 0.173 0.092 DBMET01837 0.141 0.123 DBMET01189 0.336 0.026 DBMET01191 | DBMET01191 | |
| 0.124 | 0.067 | 0.141 | Acetylcholine antagonist | 0.141 0.055 DBMET01188 0.103 0.088 DBMET01189 | DBMET01188 | |
| 0.099 | 0.043 | 0.148 | Interleukin 5 antagonist | 0.09 0.054 DBMET01188 0.082 0.069 DBMET01190 0.148 0.011 DBMET01189 | DBMET01189 | |
| 0.143 | 0.088 | 0.152 | CF transmembrane conductance regulator agonist | 0.152 0.072 DBMET01188 0.144 0.088 DBMET01837 0.13 0.119 DBMET01189 | DBMET01188 | |
| 0.072 | 0.017 | 0.072 | Nicotinic alpha3beta2 receptor antagonist | 0.057 0.03 DBMET01190 0.055 0.034 DBMET01189 | ||
| 0.059 | 0.005 | 0.059 | Vanilloid 3 antagonist | 0.037 0.03 DBMET01188 0.056 0.005 DBMET01190 0.039 0.025 DBMET01837 0.045 0.014 DBMET01189 | ||
| 0.069 | 0.014 | 0.069 | Aldosterone antagonist | 0.05 0.029 DBMET01837 | ||
| 0.075 | 0.021 | 0.075 | Calcium channel P-type blocker | 0.06 0.058 DBMET01188 0.072 0.025 DBMET01837 | ||
| 0.07 | 0.017 | 0.07 | Dihydroorotate oxidase inhibitor | 0.058 0.033 DBMET01188 0.052 0.045 DBMET01190 0.058 0.033 DBMET01189 | ||
| 0.093 | 0.041 | 0.093 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.099 | 0.048 | 0.185 | Triose-phosphate isomerase inhibitor | 0.139 0.023 DBMET01188 0.121 0.031 DBMET01190 0.133 0.026 DBMET01837 0.139 0.023 DBMET01189 0.185 0.013 DBMET01191 | DBMET01191 | |
| 0.067 | 0.018 | 0.081 | Pregnane X receptor antagonist | 0.081 0.006 DBMET01190 0.06 0.032 DBMET01837 | DBMET01190 | |
| 0.08 | 0.032 | 0.08 | Bcl2 antagonist | |||
| 0.058 | 0.011 | 0.084 | GABA uptake inhibitor | 0.062 0.009 DBMET01188 0.084 0.005 DBMET01190 0.062 0.009 DBMET01189 | DBMET01190 | |
| 0.078 | 0.03 | 0.088 | Cannabinoid CB1 receptor agonist | 0.062 0.041 DBMET01188 0.088 0.024 DBMET01190 | DBMET01190 | |
| 0.051 | 0.003 | 0.051 | Alpha 2b adrenoreceptor agonist | 0.041 0.004 DBMET01188 0.019 0.012 DBMET01837 0.046 0.004 DBMET01189 | ||
| 0.18 | 0.133 | 0.582 | Hypoglycemic | 0.253 0.075 DBMET01188 0.248 0.078 DBMET01190 0.224 0.094 DBMET01837 0.322 0.046 DBMET01189 0.582 0.009 DBMET01191 | DBMET01191 | |
| 0.054 | 0.007 | 0.054 | 5-Alpha-reductase 1 inhibitor | 0.047 0.007 DBMET01188 0.016 0.012 DBMET01190 0.016 0.013 DBMET01189 | ||
| 0.059 | 0.012 | 0.059 | Kainate receptor 2 antagonist | 0.047 0.018 DBMET01188 0.032 0.028 DBMET01837 0.048 0.017 DBMET01189 | ||
| 0.073 | 0.026 | 0.073 | Transcription factor RelA inhibitor | 0.068 0.034 DBMET01837 | ||
| 0.057 | 0.01 | 0.058 | Retinoic acid alpha receptor agonist | 0.058 0.01 DBMET01188 0.044 0.02 DBMET01190 0.04 0.025 DBMET01837 0.052 0.013 DBMET01189 | DBMET01188 | |
| 0.101 | 0.054 | 0.126 | Prolactin inhibitor | 0.126 0.034 DBMET01188 0.081 0.08 DBMET01190 0.101 0.054 DBMET01189 | DBMET01188 | |
| 0.07 | 0.024 | 0.12 | Protein 50S ribosomal subunit inhibitor | 0.047 0.043 DBMET01188 0.053 0.037 DBMET01190 0.12 0.009 DBMET01837 0.056 0.034 DBMET01189 0.117 0.01 DBMET01191 | DBMET01837 | |
| 0.21 | 0.165 | 0.757 | Antithrombotic | 0.249 0.127 DBMET01188 0.368 0.058 DBMET01190 0.196 0.182 DBMET01837 0.261 0.118 DBMET01189 0.757 0.005 DBMET01191 | DBMET01191 | |
| 0.054 | 0.009 | 0.054 | Retinoid X receptor antagonist | 0.04 0.023 DBMET01188 0.039 0.025 DBMET01190 0.045 0.017 DBMET01189 | ||
| 0.137 | 0.093 | 0.137 | GABA C receptor rho-2 antagonist | |||
| 0.062 | 0.017 | 0.127 | Estrogen receptor beta agonist | 0.053 0.019 DBMET01190 0.036 0.022 DBMET01837 0.127 0.009 DBMET01189 0.034 0.022 DBMET01191 | DBMET01189 | |
| 0.065 | 0.022 | 0.082 | Aconitate hydratase inhibitor | 0.073 0.017 DBMET01188 0.082 0.013 DBMET01190 0.073 0.017 DBMET01189 | DBMET01190 | |
| 0.073 | 0.03 | 0.103 | Biliverdin reductase inhibitor | 0.071 0.032 DBMET01188 0.103 0.018 DBMET01837 0.071 0.032 DBMET01189 | DBMET01837 | |
| 0.114 | 0.071 | 0.114 | Proteasome inhibitor | 0.102 0.084 DBMET01188 | ||
| 0.045 | 0.003 | 0.045 | Progesterone receptor B antagonist | 0.03 0.005 DBMET01190 0.021 0.011 DBMET01837 0.021 0.01 DBMET01189 | ||
| 0.054 | 0.013 | 0.056 | Retinoid X alpha receptor agonist | 0.044 0.017 DBMET01188 0.045 0.017 DBMET01190 0.056 0.012 DBMET01189 | DBMET01189 | |
| 0.084 | 0.044 | 0.158 | Porphobilinogen synthase inhibitor | 0.158 0.019 DBMET01188 0.064 0.062 DBMET01837 0.111 0.031 DBMET01189 | DBMET01188 | |
| 0.045 | 0.006 | 0.045 | Retinoic acid receptor agonist | 0.038 0.007 DBMET01188 0.021 0.02 DBMET01837 0.026 0.012 DBMET01189 | ||
| 0.047 | 0.008 | 0.047 | Retinoid X alpha receptor antagonist | 0.036 0.02 DBMET01188 0.035 0.022 DBMET01190 0.04 0.015 DBMET01189 | ||
| 0.075 | 0.038 | 0.075 | Cannabinoid receptor agonist | |||
| 0.053 | 0.017 | 0.086 | Parathyroid hormone antagonist | 0.045 0.032 DBMET01188 0.062 0.01 DBMET01190 0.086 0.004 DBMET01837 0.045 0.032 DBMET01189 | DBMET01837 | |
| 0.096 | 0.061 | 0.096 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.076 DBMET01190 | ||
| 0.072 | 0.038 | 0.072 | Exportin-1 inhibitor | |||
| 0.17 | 0.136 | 0.17 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.073 | 0.042 | 0.073 | Neuronal nicotinic receptor antagonist | 0.058 0.057 DBMET01190 0.058 0.057 DBMET01189 | ||
| 0.062 | 0.032 | 0.062 | Ryanodine receptor antagonist | 0.056 0.053 DBMET01837 | ||
| 0.107 | 0.077 | 0.107 | Anesthetic local | 0.098 0.085 DBMET01190 | ||
| 0.036 | 0.007 | 0.036 | Retinoid X gamma receptor antagonist | 0.033 0.009 DBMET01188 0.026 0.022 DBMET01837 0.035 0.007 DBMET01189 | ||
| 0.117 | 0.088 | 0.125 | Bone formation stimulant | 0.112 0.093 DBMET01190 0.125 0.081 DBMET01837 | DBMET01837 | |
| 0.059 | 0.031 | 0.093 | Estrogen agonist | 0.071 0.026 DBMET01188 0.046 0.038 DBMET01190 0.057 0.031 DBMET01837 0.093 0.019 DBMET01189 0.052 0.034 DBMET01191 | DBMET01189 | |
| 0.117 | 0.09 | 0.128 | Papain-like protease (SARS coronavirus) inhibitor | 0.128 0.064 DBMET01837 | DBMET01837 | |
| 0.083 | 0.056 | 0.083 | CC chemokine 5 receptor agonist | |||
| 0.144 | 0.118 | 0.177 | Phospholipase C inhibitor | 0.177 0.064 DBMET01188 0.169 0.074 DBMET01837 0.159 0.089 DBMET01189 | DBMET01188 | |
| 0.058 | 0.031 | 0.058 | Nicotinic receptor alpha7 subunit antagonist | 0.058 0.031 DBMET01190 | ||
| 0.031 | 0.006 | 0.031 | Retinoic acid gamma receptor agonist | 0.027 0.008 DBMET01188 0.021 0.018 DBMET01837 0.027 0.008 DBMET01189 | ||
| 0.09 | 0.065 | 0.124 | ABCA1 expression enhancer | 0.089 0.068 DBMET01188 0.121 0.03 DBMET01190 0.124 0.028 DBMET01837 0.089 0.067 DBMET01189 | DBMET01837 | |
| 0.034 | 0.009 | 0.034 | Retinoid X gamma receptor agonist | 0.028 0.012 DBMET01188 0.028 0.012 DBMET01189 | ||
| 0.063 | 0.038 | 0.065 | Alpha 2 adrenoreceptor agonist | 0.065 0.036 DBMET01188 0.064 0.038 DBMET01189 | DBMET01188 | |
| 0.029 | 0.004 | 0.029 | Retinoid X beta receptor antagonist | 0.025 0.007 DBMET01188 0.021 0.013 DBMET01190 0.028 0.005 DBMET01189 | ||
| 0.097 | 0.073 | 0.132 | Adenylate kinase inhibitor | 0.118 0.045 DBMET01188 0.132 0.035 DBMET01837 0.118 0.045 DBMET01189 | DBMET01837 | |
| 0.227 | 0.203 | 0.227 | Transcription factor inhibitor | |||
| 0.062 | 0.039 | 0.077 | Androgen agonist | 0.077 0.025 DBMET01190 0.064 0.036 DBMET01837 0.061 0.04 DBMET01189 | DBMET01190 | |
| 0.081 | 0.059 | 0.081 | Acetylcholine M3 receptor agonist | |||
| 0.039 | 0.017 | 0.101 | Melatonin 2 agonist | 0.045 0.013 DBMET01188 0.08 0.005 DBMET01190 0.101 0.004 DBMET01191 | DBMET01191 | |
| 0.092 | 0.07 | 0.092 | Electrolyte absorption antagonist | |||
| 0.053 | 0.032 | 0.053 | Prolyl endopeptidase inhibitor | 0.047 0.042 DBMET01188 | ||
| 0.027 | 0.009 | 0.071 | Vitamin D receptor antagonist | 0.027 0.008 DBMET01188 0.024 0.011 DBMET01190 0.071 0.004 DBMET01837 0.026 0.009 DBMET01189 0.023 0.013 DBMET01191 | DBMET01837 | |
| 0.03 | 0.012 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.029 0.014 DBMET01188 0.025 0.021 DBMET01190 0.029 0.014 DBMET01189 | ||
| 0.025 | 0.007 | 0.025 | Retinoic acid beta receptor agonist | 0.025 0.008 DBMET01188 0.023 0.009 DBMET01189 | ||
| 0.074 | 0.057 | 0.096 | Keratolytic | 0.096 0.033 DBMET01188 0.084 0.044 DBMET01190 0.084 0.044 DBMET01837 0.096 0.033 DBMET01189 | DBMET01189 | |
| 0.045 | 0.028 | 0.045 | Glutamate (mGluR group III) antagonist | |||
| 0.027 | 0.01 | 0.027 | Retinoid X beta receptor agonist | 0.024 0.012 DBMET01188 0.024 0.012 DBMET01189 | ||
| 0.103 | 0.087 | 0.129 | Acetylcholine muscarinic antagonist | 0.129 0.059 DBMET01188 | DBMET01188 | |
| 0.047 | 0.031 | 0.064 | Adenylate cyclase 1 inhibitor | 0.064 0.015 DBMET01837 | DBMET01837 | |
| 0.049 | 0.033 | 0.049 | Dopamine beta hydroxylase inhibitor | 0.048 0.035 DBMET01188 | ||
| 0.044 | 0.029 | 0.044 | Glutamate (mGluR4) antagonist | 0.042 0.033 DBMET01188 | ||
| 0.151 | 0.137 | 0.2 | Neurotrophic factor enhancer | 0.2 0.076 DBMET01188 0.18 0.098 DBMET01190 0.195 0.081 DBMET01837 0.198 0.079 DBMET01189 0.147 0.143 DBMET01191 | DBMET01188 | |
| 0.093 | 0.08 | 0.166 | AMP-activated protein kinase stimulant | 0.132 0.04 DBMET01188 0.161 0.022 DBMET01837 0.166 0.019 DBMET01191 | DBMET01191 | |
| 0.047 | 0.035 | 0.047 | Cholesterol esterase inhibitor | 0.043 0.041 DBMET01188 | ||
| 0.092 | 0.08 | 0.108 | Estrogen receptor beta antagonist | 0.105 0.054 DBMET01837 0.108 0.049 DBMET01189 | DBMET01189 | |
| 0.048 | 0.036 | 0.083 | Cytokine production stimulant | 0.048 0.036 DBMET01188 0.05 0.028 DBMET01190 0.083 0.005 DBMET01191 | DBMET01191 | |
| 0.025 | 0.014 | 0.048 | CYP24 inhibitor | 0.048 0.005 DBMET01837 | DBMET01837 | |
| 0.039 | 0.028 | 0.039 | Membrane dipeptidase inhibitor | 0.039 0.027 DBMET01188 0.036 0.032 DBMET01190 0.039 0.027 DBMET01189 | ||
| 0.022 | 0.012 | 0.022 | 5-Alpha-reductase 2 inhibitor | |||
| 0.055 | 0.045 | 0.055 | Aromatase inhibitor | |||
| 0.015 | 0.005 | 0.019 | Calcineurin inhibitor | 0.019 0.004 DBMET01837 | DBMET01837 | |
| 0.092 | 0.083 | 0.145 | Beta glucuronidase inhibitor | 0.145 0.027 DBMET01191 | DBMET01191 | |
| 0.063 | 0.054 | 0.17 | Phosphofructokinase-1 inhibitor | 0.118 0.026 DBMET01188 0.088 0.037 DBMET01190 0.114 0.027 DBMET01837 0.118 0.026 DBMET01189 0.17 0.015 DBMET01191 | DBMET01191 | |
| 0.034 | 0.026 | 0.052 | Progesterone antagonist | 0.052 0.017 DBMET01190 | DBMET01190 | |
| 0.058 | 0.05 | 0.067 | HIV-1 integrase (3'-Processing) inhibitor | 0.063 0.045 DBMET01188 0.067 0.041 DBMET01837 | DBMET01837 | |
| 0.017 | 0.01 | 0.025 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.025 0.004 DBMET01188 0.016 0.015 DBMET01189 0.018 0.01 DBMET01191 | DBMET01188 | |
| 0.087 | 0.081 | 0.096 | Bile acid receptor antagonist | 0.088 0.079 DBMET01188 0.086 0.084 DBMET01190 0.094 0.064 DBMET01837 0.096 0.057 DBMET01189 | DBMET01189 | |
| 0.032 | 0.025 | 0.042 | Estrogen receptor alpha agonist | 0.042 0.02 DBMET01190 0.029 0.027 DBMET01189 | DBMET01190 | |
| 0.011 | 0.005 | 0.011 | Progesterone receptor A antagonist | |||
| 0.021 | 0.015 | 0.021 | Kainate receptor 1 antagonist | 0.018 0.017 DBMET01189 | ||
| 0.119 | 0.115 | 0.152 | Protein-tyrosine phosphatase inhibitor | 0.152 0.077 DBMET01188 0.134 0.097 DBMET01837 | DBMET01188 | |
| 0.051 | 0.047 | 0.079 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.078 0.021 DBMET01188 0.05 0.049 DBMET01190 0.079 0.021 DBMET01837 0.078 0.021 DBMET01189 | DBMET01837 | |
| 0.018 | 0.015 | 0.018 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.017 0.016 DBMET01837 | ||
| 0.016 | 0.013 | 0.024 | Vitamin D receptor agonist | 0.016 0.013 DBMET01188 0.024 0.005 DBMET01190 0.018 0.009 DBMET01837 0.022 0.006 DBMET01191 | DBMET01190 | |
| 0.009 | 0.007 | 0.009 | Corticotropin releasing factor antagonist | 0.009 0.007 DBMET01189 | ||
| 0.142 | 0.14 | 0.165 | Anticonvulsant | 0.144 0.137 DBMET01188 0.165 0.112 DBMET01190 | DBMET01190 | |
| 0.03 | 0.028 | 0.03 | Calcium release-activated channel blocker | |||
| 0.014 | 0.013 | 0.016 | NMDA receptor phencyclidine site antagonist | 0.016 0.01 DBMET01189 | DBMET01189 | |
| 0.069 | 0.069 | 0.107 | Estrogen receptor alpha antagonist | 0.107 0.024 DBMET01837 | DBMET01837 | |
| 0.047 | 0.047 | 0.068 | Acyl-CoA dehydrogenase inhibitor | 0.063 0.031 DBMET01188 0.068 0.028 DBMET01837 0.063 0.031 DBMET01189 | DBMET01837 | |
| 0.143 | 0.143 | 0.177 | Insulin sensitizer | 0.177 0.099 DBMET01188 | DBMET01188 | |
| 0.003 | 0.004 | 0.005 | Vitamin D-like | 0.005 0.002 DBMET01837 | DBMET01837 | |
| 0.073 | 0.075 | 0.122 | Antineoplastic alkaloid | 0.101 0.047 DBMET01188 0.09 0.055 DBMET01837 0.122 0.037 DBMET01189 | DBMET01189 | |
| 0.02 | 0.022 | 0.033 | Prostaglandin F2 alpha agonist | 0.021 0.019 DBMET01188 0.031 0.008 DBMET01190 0.033 0.008 DBMET01837 0.021 0.019 DBMET01189 | DBMET01837 | |
| 0.064 | 0.066 | 0.087 | Glutamate dehydrogenase inhibitor | 0.076 0.048 DBMET01188 0.087 0.039 DBMET01837 0.076 0.048 DBMET01189 | DBMET01837 | |
| 0.027 | 0.032 | 0.032 | ATP citrate lysase inhibitor | 0.032 0.022 DBMET01837 | DBMET01837 | |
| 0.028 | 0.036 | 0.034 | Glutamate (mGluR3) agonist | 0.032 0.023 DBMET01190 0.032 0.023 DBMET01837 0.034 0.019 DBMET01189 | DBMET01189 | |
| 0.238 | 0.246 | 0.312 | 5 Hydroxytryptamine release inhibitor | 0.312 0.152 DBMET01190 0.27 0.202 DBMET01191 | DBMET01190 | |
| 0.045 | 0.053 | 0.078 | Factor III inhibitor | 0.061 0.016 DBMET01188 0.078 0.008 DBMET01189 | DBMET01189 | |
| 0.032 | 0.042 | 0.042 | Glutamate (mGluR8) agonist | 0.036 0.031 DBMET01188 0.042 0.02 DBMET01189 | DBMET01189 | |
| 0.034 | 0.044 | 0.041 | Guanylate cyclase inhibitor | 0.041 0.032 DBMET01837 | DBMET01837 | |
| 0.013 | 0.024 | 0.027 | Telomerase stimulant | 0.016 0.015 DBMET01188 0.02 0.008 DBMET01190 0.018 0.01 DBMET01837 0.016 0.015 DBMET01189 0.027 0.004 DBMET01191 | DBMET01191 | |
| 0.016 | 0.028 | 0.021 | Geranylgeranyltransferase inhibitor | 0.021 0.017 DBMET01188 | DBMET01188 | |
| 0.006 | 0.018 | 0.016 | Antibiotic Macrolide-like | 0.016 0.009 DBMET01837 0.016 0.009 DBMET01191 | DBMET01191 | |
| 0.055 | 0.068 | 0.094 | Interferon inducer | 0.094 0.015 DBMET01188 0.088 0.018 DBMET01837 0.071 0.033 DBMET01189 0.064 0.044 DBMET01191 | DBMET01188 | |
| 0.043 | 0.057 | 0.051 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.051 0.041 DBMET01190 | DBMET01190 | |
| 0.039 | 0.054 | 0.075 | Glucose-6-phosphate isomerase inhibitor | 0.054 0.024 DBMET01188 0.059 0.02 DBMET01190 0.054 0.025 DBMET01837 0.054 0.024 DBMET01189 0.075 0.01 DBMET01191 | DBMET01191 | |
| 0.069 | 0.085 | 0.093 | MAP kinase kinase 7 inhibitor | 0.075 0.062 DBMET01188 0.073 0.068 DBMET01837 0.093 0.02 DBMET01189 | DBMET01189 | |
| 0.025 | 0.043 | 0.046 | Melatonin 1 agonist | 0.04 0.015 DBMET01190 0.046 0.011 DBMET01191 | DBMET01191 | |
| 0.052 | 0.071 | 0.1 | Lipase inhibitor | 0.1 0.027 DBMET01188 | DBMET01188 | |
| 0.077 | 0.095 | 0.232 | UDP-glucose 4-epimerase inhibitor | 0.116 0.046 DBMET01188 0.106 0.055 DBMET01190 0.12 0.043 DBMET01837 0.116 0.046 DBMET01189 0.232 0.015 DBMET01191 | DBMET01191 | |
| 0.023 | 0.042 | 0.033 | Hedgehog signaling activator | 0.033 0.009 DBMET01190 | DBMET01190 | |
| 0.023 | 0.043 | 0.03 | Melatonin agonist | 0.03 0.028 DBMET01190 | DBMET01190 | |
| 0.093 | 0.116 | 0.129 | Estrogen antagonist | 0.129 0.039 DBMET01837 0.11 0.075 DBMET01189 | DBMET01837 | |
| 0.071 | 0.097 | 0.275 | Monophenol monooxygenase inhibitor | 0.095 0.08 DBMET01188 0.12 0.062 DBMET01190 0.275 0.021 DBMET01191 | DBMET01191 | |
| 0.042 | 0.069 | 0.103 | Sphingosine kinase 2 inhibitor | 0.064 0.027 DBMET01188 0.052 0.044 DBMET01837 0.103 0.007 DBMET01189 | DBMET01189 | |
| 0.013 | 0.041 | 0.034 | Antibiotic Anthracycline-like | 0.018 0.016 DBMET01837 0.034 0.003 DBMET01191 | DBMET01191 | |
| 0.054 | 0.082 | 0.071 | Aminopeptidase I inhibitor | 0.071 0.052 DBMET01190 | DBMET01190 | |
| 0.02 | 0.048 | 0.035 | Thymidine phosphorylase inhibitor | 0.035 0.008 DBMET01189 | DBMET01189 | |
| 0.07 | 0.102 | 0.166 | NADH dehydrogenase inhibitor | 0.091 0.055 DBMET01188 0.083 0.068 DBMET01190 0.096 0.048 DBMET01837 0.091 0.055 DBMET01189 0.166 0.014 DBMET01191 | DBMET01191 | |
| 0.061 | 0.093 | 0.11 | Interferon agonist | 0.11 0.022 DBMET01188 0.101 0.028 DBMET01837 0.083 0.047 DBMET01189 0.076 0.059 DBMET01191 | DBMET01188 | |
| 0.123 | 0.156 | 0.19 | I kappa B kinase epsilon inhibitor | 0.19 0.079 DBMET01189 | DBMET01189 | |
| 0.045 | 0.08 | 0.116 | Sphingosine kinase inhibitor | 0.063 0.034 DBMET01188 0.069 0.025 DBMET01837 0.116 0.005 DBMET01189 | DBMET01189 | |
| 0.071 | 0.106 | 0.082 | Estrogen-related receptor beta agonist | 0.082 0.059 DBMET01190 | DBMET01190 | |
| 0.011 | 0.047 | 0.033 | Purinergic P2Y12 antagonist | 0.025 0.014 DBMET01190 0.029 0.012 DBMET01189 0.033 0.011 DBMET01191 | DBMET01191 | |
| 0.019 | 0.057 | 0.029 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.029 0.026 DBMET01190 | DBMET01190 | |
| 0.113 | 0.153 | 0.145 | Pregnane X receptor agonist | 0.137 0.082 DBMET01190 0.145 0.063 DBMET01837 | DBMET01837 | |
| 0.064 | 0.104 | 0.085 | Aminopeptidase B inhibitor | 0.085 0.077 DBMET01190 | DBMET01190 | |
| 0.024 | 0.065 | 0.06 | Purinergic P2Y antagonist | 0.06 0.019 DBMET01189 0.041 0.035 DBMET01191 | DBMET01189 | |
| 0.087 | 0.132 | 0.126 | Toll-Like receptor 2 antagonist | 0.125 0.073 DBMET01188 0.126 0.072 DBMET01189 | DBMET01189 | |
| 0.015 | 0.061 | 0.031 | Prostaglandin agonist | 0.031 0.021 DBMET01189 | DBMET01189 | |
| 0.094 | 0.141 | 0.119 | Sphingosine 1-phosphate receptor 4 antagonist | 0.119 0.075 DBMET01190 | DBMET01190 | |
| 0.034 | 0.081 | 0.051 | Argininosuccinate synthase inhibitor | 0.051 0.045 DBMET01837 | DBMET01837 | |
| 0.011 | 0.059 | 0.027 | RNA-directed RNA polymerase stimulant | 0.027 0.023 DBMET01837 | DBMET01837 | |
| 0.016 | 0.069 | 0.088 | Sodium/glucose cotransporter inhibitor | 0.024 0.022 DBMET01837 0.029 0.013 DBMET01189 0.088 0.003 DBMET01191 | DBMET01191 | |
| 0.067 | 0.121 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.072 DBMET01188 0.081 0.072 DBMET01189 | DBMET01189 | |
| 0.066 | 0.121 | 0.079 | Thioredoxin reductase inhibitor | 0.079 0.064 DBMET01188 | DBMET01188 | |
| 0.151 | 0.207 | 0.172 | Nitric-oxide synthase stimulant | 0.169 0.155 DBMET01188 0.172 0.148 DBMET01837 | DBMET01837 | |
| 0.082 | 0.139 | 0.181 | Cyclooxygenase 3 inhibitor | 0.103 0.098 DBMET01189 0.181 0.027 DBMET01191 | DBMET01191 | |
| 0.031 | 0.089 | 0.055 | Alcohol oxidase inhibitor | 0.055 0.04 DBMET01190 0.053 0.042 DBMET01837 | DBMET01190 | |
| 0.006 | 0.064 | 0.083 | Prostacyclin agonist | 0.083 0.004 DBMET01189 | DBMET01189 | |
| 0.034 | 0.093 | 0.068 | Carbamoyl phosphate synthetase inhibitor | 0.068 0.036 DBMET01190 0.057 0.046 DBMET01837 | DBMET01190 | |
| 0.073 | 0.14 | 0.091 | Phosphodiesterase 6D inhibitor | 0.091 0.073 DBMET01191 | DBMET01191 | |
| 0.032 | 0.1 | 0.106 | Alpha-mannosidase inhibitor | 0.056 0.033 DBMET01188 0.057 0.031 DBMET01190 0.053 0.038 DBMET01837 0.066 0.02 DBMET01189 0.106 0.005 DBMET01191 | DBMET01191 | |
| 0.119 | 0.188 | 0.414 | Platelet antagonist | 0.181 0.116 DBMET01190 0.291 0.056 DBMET01189 0.414 0.024 DBMET01191 | DBMET01191 | |
| 0.061 | 0.13 | 0.086 | Creatine kinase inhibitor | 0.086 0.077 DBMET01190 0.085 0.079 DBMET01837 | DBMET01190 | |
| 0.01 | 0.087 | 0.08 | Sodium/glucose cotransporter 2 inhibitor | 0.024 0.023 DBMET01837 0.029 0.014 DBMET01189 0.08 0.004 DBMET01191 | DBMET01191 | |
| 0.024 | 0.105 | 0.067 | Sphingosine kinase 1 inhibitor | 0.067 0.007 DBMET01189 | DBMET01189 | |
| 0.009 | 0.09 | 0.023 | Corticosteroid-like | 0.023 0.012 DBMET01191 | DBMET01191 | |
| 0.168 | 0.249 | 0.393 | Histamine release inhibitor | 0.393 0.079 DBMET01191 | DBMET01191 | |
| 0.054 | 0.141 | 0.091 | HIV-1 integrase (Overall Integration) inhibitor | 0.091 0.064 DBMET01188 | DBMET01188 | |
| 0.149 | 0.243 | 0.295 | Vasodilator, peripheral | 0.226 0.148 DBMET01188 0.193 0.184 DBMET01190 0.251 0.127 DBMET01837 0.237 0.138 DBMET01189 0.295 0.1 DBMET01191 | DBMET01191 | |
| 0.059 | 0.154 | 0.094 | Chelator | 0.094 0.086 DBMET01188 | DBMET01188 | |
| 0.02 | 0.12 | 0.096 | Mannosidase inhibitor | 0.04 0.039 DBMET01188 0.051 0.024 DBMET01189 0.096 0.006 DBMET01191 | DBMET01191 | |
| 0.011 | 0.111 | 0.036 | Prostaglandin D2 agonist | 0.036 0.015 DBMET01189 | DBMET01189 | |
| 0.006 | 0.108 | 0.036 | Arginase inhibitor | 0.036 0.026 DBMET01191 | DBMET01191 | |
| 0.042 | 0.144 | 0.071 | Lipocortins synthesis agonist | 0.06 0.037 DBMET01190 0.058 0.041 DBMET01837 0.071 0.021 DBMET01191 | DBMET01191 | |
| 0.014 | 0.116 | 0.038 | HMG CoA reductase inhibitor | 0.038 0.017 DBMET01837 | DBMET01837 | |
| 0.029 | 0.132 | 0.159 | HIV-1 reverse transcriptase inhibitor | 0.159 0.013 DBMET01190 | DBMET01190 | |
| 0.065 | 0.17 | 0.181 | Toll-Like receptor 4 antagonist | 0.095 0.079 DBMET01188 0.091 0.086 DBMET01837 0.095 0.079 DBMET01189 0.181 0.009 DBMET01191 | DBMET01191 | |
| 0.059 | 0.168 | 0.259 | DNA polymerase I inhibitor | 0.189 0.032 DBMET01190 0.259 0.016 DBMET01191 | DBMET01191 | |
| 0.119 | 0.229 | 0.301 | DNA damaging | 0.18 0.134 DBMET01190 0.301 0.057 DBMET01191 | DBMET01191 | |
| 0.086 | 0.206 | 0.239 | NOS3 expression enhancer | 0.14 0.083 DBMET01837 0.239 0.029 DBMET01191 | DBMET01191 | |
| 0.101 | 0.228 | 0.182 | Lipocortins synthesis antagonist | 0.182 0.069 DBMET01190 0.168 0.083 DBMET01837 0.171 0.079 DBMET01191 | DBMET01190 | |
| 0.076 | 0.203 | 0.156 | Neurotrophic factor | 0.156 0.054 DBMET01837 | DBMET01837 | |
| 0.031 | 0.16 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.054 DBMET01191 | DBMET01191 | |
| 0.073 | 0.204 | 0.131 | Cholinergic | 0.131 0.095 DBMET01190 | DBMET01190 | |
| 0.091 | 0.227 | 0.203 | Aldehyde oxidase inhibitor | 0.203 0.103 DBMET01190 | DBMET01190 | |
| 0.069 | 0.205 | 0.143 | Interleukin 4 antagonist | 0.143 0.057 DBMET01191 | DBMET01191 | |
| 0.055 | 0.192 | 0.297 | Amylase inhibitor | 0.112 0.086 DBMET01188 0.112 0.086 DBMET01189 0.297 0.019 DBMET01191 | DBMET01191 | |
| 0.132 | 0.273 | 0.375 | Vasodilator, coronary | 0.269 0.116 DBMET01837 0.375 0.044 DBMET01191 | DBMET01191 | |
| 0.053 | 0.194 | 0.082 | mTOR complex 2 inhibitor | 0.082 0.064 DBMET01190 | DBMET01190 | |
| 0.077 | 0.226 | 0.135 | Mannose-6-phosphate isomerase inhibitor | 0.12 0.1 DBMET01190 0.135 0.08 DBMET01191 | DBMET01191 | |
| 0.03 | 0.186 | 0.053 | Glucosylceramidase inhibitor | 0.053 0.042 DBMET01189 | DBMET01189 | |
| 0.013 | 0.175 | 0.059 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.059 0.023 DBMET01190 | DBMET01190 | |
| 0.061 | 0.223 | 0.141 | Hedgehog signaling inhibitor | 0.141 0.027 DBMET01190 | DBMET01190 | |
| 0.132 | 0.304 | 0.286 | Sodium/bile acid cotransporter inhibitor | 0.286 0.092 DBMET01190 0.249 0.129 DBMET01837 0.21 0.175 DBMET01191 | DBMET01190 | |
| 0.05 | 0.235 | 0.107 | Acetylcholinesterase inhibitor | 0.107 0.093 DBMET01190 | DBMET01190 | |
| 0.042 | 0.235 | 0.065 | Prolactin release inhibitor | 0.065 0.034 DBMET01188 0.065 0.033 DBMET01189 | DBMET01189 | |
| 0.069 | 0.265 | 0.163 | Hexokinase inhibitor | 0.163 0.065 DBMET01191 | DBMET01191 | |
| 0.078 | 0.283 | 0.142 | Tumour necrosis factor antagonist | 0.142 0.111 DBMET01190 | DBMET01190 | |
| 0.022 | 0.238 | 0.077 | Heparanase inhibitor | 0.077 0.008 DBMET01191 | DBMET01191 | |
| 0.07 | 0.287 | 0.166 | P-glycoprotein inhibitor | 0.166 0.094 DBMET01837 0.142 0.13 DBMET01191 | DBMET01837 | |
| 0.008 | 0.24 | 0.037 | Protein 30S ribosomal subunit inhibitor | 0.037 0.011 DBMET01191 | DBMET01191 | |
| 0.012 | 0.263 | 0.067 | Neuraminidase inhibitor | 0.067 0.036 DBMET01191 | DBMET01191 | |
| 0.099 | 0.36 | 0.534 | Immunomodulator | 0.213 0.149 DBMET01188 0.449 0.032 DBMET01837 0.534 0.019 DBMET01191 | DBMET01191 | |
| 0.013 | 0.274 | 0.036 | MAP3K5 inhibitor | 0.036 0.033 DBMET01190 | DBMET01190 | |
| 0.021 | 0.286 | 0.071 | Topoisomerase II alpha inhibitor | 0.071 0.06 DBMET01191 | DBMET01191 | |
| 0.025 | 0.341 | 0.113 | Topoisomerase II inhibitor | 0.113 0.073 DBMET01191 | DBMET01191 | |
| 0.02 | 0.355 | 0.167 | Topoisomerase I inhibitor | 0.167 0.035 DBMET01191 | DBMET01191 | |
| 0.081 | 0.417 | 0.221 | Antiobesity | 0.221 0.186 DBMET01191 | DBMET01191 | |
| 0.014 | 0.353 | 0.085 | Neuraminidase (influenza) inhibitor | 0.085 0.022 DBMET01191 | DBMET01191 | |
| 0.03 | 0.379 | 0.218 | Lipid peroxidase inhibitor | 0.218 0.035 DBMET01191 | DBMET01191 | |
| 0.042 | 0.419 | 0.167 | Antiamyloidogenic | 0.167 0.125 DBMET01191 | DBMET01191 | |
| 0.122 | 0.499 | 0.339 | Calcium channel L-type activator | 0.339 0.126 DBMET01188 0.339 0.126 DBMET01189 | DBMET01189 | |
| 0.008 | 0.39 | 0.053 | Acetyl-CoA transferase inhibitor | 0.053 0.037 DBMET01190 | DBMET01190 | |
| 0.036 | 0.423 | 0.318 | Hypolipemic | 0.158 0.129 DBMET01190 0.159 0.128 DBMET01837 0.318 0.044 DBMET01191 | DBMET01191 | |
| 0.091 | 0.496 | 0.349 | Peptidyltransferase inhibitor | 0.179 0.13 DBMET01190 0.209 0.088 DBMET01837 0.349 0.012 DBMET01191 | DBMET01191 | |
| 0.038 | 0.473 | 0.118 | Hemostatic | 0.118 0.117 DBMET01191 | DBMET01191 | |
| 0.071 | 0.562 | 0.73 | Cyclophilin D inhibitor | 0.269 0.192 DBMET01188 0.612 0.025 DBMET01190 0.301 0.162 DBMET01189 0.73 0.011 DBMET01191 | DBMET01191 | |
| 0.009 | 0.52 | 0.042 | Neuraminidase (Influenza A) inhibitor | 0.042 0.038 DBMET01191 | DBMET01191 | |
| 0.022 | 0.567 | 0.197 | Cell adhesion inhibitor | 0.197 0.025 DBMET01191 | DBMET01191 | |
| 0.036 | 0.596 | 0.114 | DNA repair enzyme inhibitor | 0.114 0.086 DBMET01191 | DBMET01191 | |
| 0.01 | 0.576 | 0.036 | Toll-Like receptor 4 agonist | 0.036 0.006 DBMET01191 | DBMET01191 | |
| 0.005 | 0.597 | 0.039 | Liver X receptor antagonist | 0.039 0.014 DBMET01190 | DBMET01190 | |
| 0.018 | 0.639 | 0.069 | Adenine nucleotide translocase inhibitor | 0.069 0.016 DBMET01191 | DBMET01191 | |
| 0.011 | 0.635 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.058 0.026 DBMET01191 | DBMET01191 | |
| 0.009 | 0.65 | 0.131 | Acetyl-CoA transferase 2 inhibitor | 0.131 0.004 DBMET01190 0.087 0.008 DBMET01191 | DBMET01190 | |
| 0.021 | 0.691 | 0.118 | mTOR complex 1 inhibitor | 0.118 0.031 DBMET01837 | DBMET01837 | |
| 0.023 | 0.725 | 0.366 | Toll-Like receptor 7 agonist | 0.366 0.074 DBMET01190 | DBMET01190 | |
| 0.009 | 0.716 | 0.064 | Antibiotic Aminoglycoside-like | 0.064 0.007 DBMET01191 | DBMET01191 | |
| 0.021 | 0.738 | 0.366 | Toll-Like receptor agonist | 0.366 0.075 DBMET01190 | DBMET01190 | |
| 0.006 | 0.752 | 0.133 | Cyclooxygenase 1 inhibitor | 0.133 0.068 DBMET01190 | DBMET01190 | |
| 0.004 | 0.751 | 0.029 | Liver X receptor alpha antagonist | 0.029 0.02 DBMET01190 | DBMET01190 | |
| 0.007 | 0.772 | 0.129 | Anticoagulant | 0.129 0.101 DBMET01191 | DBMET01191 | |
| 0.004 | 0.79 | 0.338 | Selectin antagonist | 0.338 0.004 DBMET01191 | DBMET01191 | |
| 0.005 | 0.856 | 0.094 | Cell adhesion molecule inhibitor | 0.094 0.039 DBMET01191 | DBMET01191 | |
| 0.004 | 0.864 | 0.081 | Liver X receptor agonist | 0.081 0.01 DBMET01190 | DBMET01190 | |
| 0.046 | 0.927 | 0.129 | CC chemokine 6 receptor antagonist | 0.129 0.074 DBMET01191 | DBMET01191 | |
| 0.005 | 0.915 | 0.184 | Thrombolytic | 0.184 0.06 DBMET01191 | DBMET01191 | |
| 0.011 | 0.935 | 0.128 | MAP3K9 inhibitor | 0.128 0.098 DBMET01190 | DBMET01190 | |
| 0.006 | 0.98 | 0.065 | Factor IXa inhibitor | 0.065 0.023 DBMET01191 | DBMET01191 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |